Download PDF
Zentralbl Chir 2010; 135(1): 92-94
DOI: 10.1055/s-0029-1224605
Kommentar

© Georg Thieme Verlag Stuttgart ˙ New York

Kommentar zum Artikel „Operative Techniken und deren Outcome in der metabolischen Chirurgie: Sleeve-Gastrektomie“ von T. P. Hüttl et al.

Comment on the Article “Operative Techniques and Outcomes in Metabolic Surgery: Sleeve Gastrectomy”M. Bueter1 , A. Thalheimer2 , C. Jurowich2 , M. Fein2 , C. T. Germer2
  • 1Imperial College London, Hammersmith Hospital, Department for Investigative Medicine, London, United Kingdom
  • 2Universitätsklinik Würzburg, Zentrum Operative Medizin, Klinik & Poliklinik für Allgemein- und Viszeralchirurgie, Gefäß- und Kinderchirurgie, Würzburg, Germany
Further Information

Publication History

Publication Date:
26 February 2010 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Der Übersichtsartikel „Operative Techniken und deren Outcome in der metabolischen Chirurgie: Sleeve-Gastrektomie“ der Kollegen Hüttl et al. beschäftigt sich mit der laparoskopischen Schlauch­magenoperation („Sleeve-Gastrektomie“) zur operativen Therapie der morbiden Adipositas (Zentralblatt für Chirurgie 2009; 134: 24–31). Nach Analyse der verfügbaren Literatur und eigener Ergebnisse kommen die Autoren zu dem Schluss, dass die laparoskopische Schlauchmagenoperation heute als ein effektiver Standardeingriff zur Therapie der Adipositas angesehen werden darf. Wir möchten ­einige Inhalte des Artikels kommentieren. 

Abstract

The review article “Operative Techniques and Outcomes in Metabolic Surgery: ­Sleeve Gastrectomy” by Hüttl et al. is con­cerned with laparoscopic sleeve stomach operations (“sleeve gastrectomy”) for the surgical treatment of morbid obesity (Zentralblatt für Chirurgie 2009; 134: 24–31). After an analysis of the available literature and own results, the authors concluded that the laparoscopic sleeve operation is established today as an effective standard procedure in the therapy for obesity. We would like to comment on the content of this article. 

Literatur

  • 1 Baggio L L, Drucker D J. Biology of incretins: GLP-1 and GIP.  Gastroenterology. 2007;  132 2131-2157
    CrossrefPubMedGoogle Scholar
  • 2 Batterham R L, Cohen M A, Ellis S M et al. Inhibition of food intake in obese subjects by peptide YY3–36.  N Engl J Med. 2003;  349 941-948
    CrossrefPubMedGoogle Scholar
  • 3 Batterham R L, Cowley M A, Small C J et al. Gut hormone PYY(3–36) physiologically inhibits food intake.  Nature. 2002;  418 650-654
    CrossrefPubMedGoogle Scholar
  • 4 Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.  Am J Med. 2009;  122 248-256
    CrossrefPubMedGoogle Scholar
  • 5 Couce M E, Cottam D, Esplen J et al. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer.  Obes Surg. 2006;  16 870-878
    CrossrefPubMedGoogle Scholar
  • 6 Coupaye M, Puchaux K, Bogard C et al. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study.  Obes Surg. 2009;  19 56-65
    CrossrefPubMedGoogle Scholar
  • 7 Cummings D E, Purnell J Q, Frayo R S et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.  Diabetes. 2001;  50 1714-1719
    CrossrefPubMedGoogle Scholar
  • 8 Cummings D E, Weigle D S, Frayo R S et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.  N Engl J Med. 2002;  346 1623-1630
    CrossrefPubMedGoogle Scholar
  • 9 de Castro C M, de Lima Montebelo M I, Rasera Jr I et al. Effects of Roux-en-Y gastric bypass on resting energy expenditure in women.  Obes Surg. 2008;  18 1376-1380
    CrossrefPubMedGoogle Scholar
  • 10 Edwards C M, Stanley S A, Davis R et al. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers.  Am J Physiol Endocrinol Metab. 2001;  281 E 155-E 161
    PubMedGoogle Scholar
  • 11 Edwards C M, Todd J F, Mahmoudi M et al. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9–39.  Diabetes. 1999;  48 86-93
    CrossrefPubMedGoogle Scholar
  • 12 English P J, Ghatei M A, Malik I A et al. Food fails to suppress ghrelin levels in obese humans.  J Clin Endocrinol Metab. 2002;  87 2984
    CrossrefPubMedGoogle Scholar
  • 13 Furnes M W, Tommeras K, Arum C J et al. Gastric bypass surgery causes body weight loss without reducing food intake in rats.  Obes Surg. 2008;  18 415-422
    CrossrefPubMedGoogle Scholar
  • 14 Guerci B, Martin C S. Exenatide: its position in the treatment of type 2 diabetes.  Ann Endocrinol (Paris). 2008;  69 201-209
    PubMedGoogle Scholar
  • 15 Holdstock C, Engstrom B E, Ohrvall M et al. Ghrelin and adipose tissue regulatory pep­tides: effect of gastric bypass surgery in ­obese humans.  J Clin Endocrinol Metab. 2003;  88 3177-3183
    CrossrefPubMedGoogle Scholar
  • 16 Karamanakos S N, Vagenas K, Kalfarentzos F et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gas­tric bypass and sleeve gastrectomy: a pro­spective, double blind study.  Ann Surg. 2008;  247 401-407
    CrossrefPubMedGoogle Scholar
  • 17 Korner J, Bessler M, Cirilo L J et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.  J Clin Endocrinol Metab. 2005;  90 359-365
    CrossrefPubMedGoogle Scholar
  • 18 Laferrere B, Heshka S, Wang K et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.  Diabetes Care. 2007;  30 1709-1716
    CrossrefPubMedGoogle Scholar
  • 19 le Roux C W, Aylwin S J, Batterham R L et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic pa­ram­eters.  Ann Surg. 2006;  243 108-114
    CrossrefPubMedGoogle Scholar
  • 20 le Roux C W, Patterson M, Vincent R P et al. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects.  J Clin Endocrinol Metab. 2005;  90 1068-1071
    CrossrefPubMedGoogle Scholar
  • 21 le Roux C W, Welbourn R, Werling M et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.  Ann Surg. 2007;  246 780-785
    CrossrefPubMedGoogle Scholar
  • 22 Lee H, Te C, Koshy S et al. Does ghrelin really matter after bariatric surgery?.  Surg Obes Relat Dis. 2006;  2 538-548
    CrossrefPubMedGoogle Scholar
  • 23 Mancini M C, Costa A P, de Melo M E et al. ­Effect of gastric bypass on spontaneous growth hormone and ghrelin release pro­files.  Obesity (Silver Spring). 2006;  14 383-387
    CrossrefPubMedGoogle Scholar
  • 24 McIntyre N, Holdsworth C D, Turner D S. New interpretation of oral glucose tolerance.  Lancet. 1964;  2 20-21
    CrossrefPubMedGoogle Scholar
  • 25 Murakami N, Hayashida T, Kuroiwa T et al. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats.  J Endocrinol. 2002;  174 283-288
    CrossrefPubMedGoogle Scholar
  • 26 Murphy K G, Bloom S R. Gut hormones and the regulation of energy homeostasis.  Nature. 2006;  444 854-859
    CrossrefPubMedGoogle Scholar
  • 27 Nadreau E, Baraboi E D, Samson P et al. Effects of the biliopancreatic diversion on energy balance in the rat.  Int J Obes (Lond). 2006;  30 419-429
    CrossrefPubMedGoogle Scholar
  • 28 Neary N M, Small C J, Druce M R et al. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.  Endocrinology. 2005;  146 5120-5127
    CrossrefPubMedGoogle Scholar
  • 29 Pories W J, Albrecht R J. Etiology of type II diabetes mellitus: role of the foregut.  World J Surg. 2001;  25 527-531
    CrossrefPubMedGoogle Scholar
  • 30 Pournaras D J, le Roux C W. After bariatric surgery what vitamins should be measured and what supplements should be given?.  Clin Endocrinol (Oxf). 2009;  ,  Epub ahead of print
    CrossrefPubMedGoogle Scholar
  • 31 Rubino F, Gagner M. Weight loss and plasma ghrelin levels.  N Engl J Med. 2002;  347 1379-1381
    CrossrefPubMedGoogle Scholar
  • 32 Rubino F, Gagner M, Gentileschi P et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.  Ann Surg. 2004;  240 236-242
    CrossrefPubMedGoogle Scholar
  • 33 Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal mod­el of type 2 diabetes: a new perspective for an old disease.  Ann Surg. 2004;  239 1-11
    CrossrefPubMedGoogle Scholar
  • 34 Stenstrom B, Zhao C M, Tommeras K et al. Is gastrin partially responsible for body weight reduction after gastric bypass?.  Eur Surg Res. 2006;  38 94-101
    CrossrefPubMedGoogle Scholar
  • 35 Tang-Christensen M, Larsen P J, Goke R et al. Central administration of GLP-1-(7-36) ­amide inhibits food and water intake in rats.  Am J Physiol. 1996;  271 (4 Pt 2) R 848-R 856
    PubMedGoogle Scholar
  • 36 Wren A M, Seal L J, Cohen M A et al. Ghrelin ­enhances appetite and increases food intake in humans.  J Clin Endocrinol Metab. 2001;  86 5992
    CrossrefPubMedGoogle Scholar
  • 37 Wren A M, Small C J, Abbott C R et al. Ghrelin causes hyperphagia and obesity in rats.  Diabetes. 2001;  50 2540-2547
    CrossrefPubMedGoogle Scholar

Dr. Marco Bueter

Imperial College London · Hammersmith Hospital · Department for Investigative Medicine

Du Cane Road

W12 0NN London

United Kingdom

Phone: 00 44 / (0) 79 70 71 94 53

Fax: 00 44 / (0) 20 83 83 83 20

Email: m.bueter@imperial.ac.uk